Akkermansia muciniphila improves gastric cancer treatment by modulating the immune microenvironment
Future Microbiology · 2024
DOI: 10.2217/fmb-2023-0210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Microbiology, 2024. Verfasst von Jianming Fang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Pancreatic Surgery, GuangFu Oncology Hospital, Jinhua, 321000, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Akkermansia, Tumor Microenvironment, Gastrointestinal Microbiome. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Social Development Project Fund of Jinhua Science and Technology Bureau in Zhejiang Province.
Abstract (Originalsprache)
Background
Gut microbiota is pivotal in tumor occurrence and development, and there is a close relationship between Akkermansia muciniphila (AKK) and cancer immunotherapy.
Methods
The effects of AKK and its outer membrane proteins on gastric cancer (GC) were evaluated in vitro and in vivo using cell counting kit-8 assay, flow cytometry, western blotting, ELISA, immunohistochemistry and immunofluorescence.
Results
AKK outer membrane protein facilitated apoptosis of GC cells and exerted an immunostimulatory effect (by promoting M1 polarization of macrophages, enhancing expression of cytotoxic T-lymphocyte-related cytokines and suppressing that of Treg-related cytokines). Additionally, AKK and its formulation could inhibit tumor growth of GC and enhance the infiltration of immune cells in tumor tissues.
Conclusion
AKK could improve GC treatment by modulating the immune microenvironment. Akkermansia muciniphila (AKK) is a type of bacteria found in the human gut that is good for the immune system. We wanted to investigate the effect of AKK on cancer. We extracted a protein from AKK called Amuc. AKK and Amuc inhibited the growth of stomach cancer by encouraging the action of immune cells. AKK may therefore be able to treat stomach cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Pancreatic Surgery, GuangFu Oncology Hospital, Jinhua, 321000, China.
ORCID-Profile: Jianxin Huang
Förderung
- Social Development Project Fund of Jinhua Science and Technology Bureau in Zhejiang Province
Zitieren
APA
Fang, J., Zhang, H., Zhang, X., Lu, X., Liu, J., Li, H., & Huang, J. (2024). Akkermansia muciniphila improves gastric cancer treatment by modulating the immune microenvironment. Future Microbiology. https://doi.org/10.2217/fmb-2023-0210
Vancouver
Fang J, Zhang H, Zhang X, Lu X, Liu J, Li H, et al. Akkermansia muciniphila improves gastric cancer treatment by modulating the immune microenvironment. Future Microbiology. 2024. doi:10.2217/fmb-2023-0210
BibTeX
@article{Fang2024,
author = {Fang, Jianming and Zhang, Huizhong and Zhang, Xiaodong and Lu, Xiaolong and Liu, Junjie and Li, Haiyang and Huang, Jianxin},
title = {Akkermansia muciniphila improves gastric cancer treatment by modulating the immune microenvironment},
journal = {Future Microbiology},
year = {2024},
doi = {10.2217/fmb-2023-0210}
}
EUVIMED